Phase I/II study of nab-paclitaxel (nab-P) with cisplatin (C) and thoracic radiation (TRT) in patients with locally advanced NSCLC: Safety results of phase I part.

Hidetoshi Hayashi,Masakazu Ogura,Takashi Niwa,Satoshi Ikeo,Takashi Yokoi,Yoshitaro Torii,Kunio Okamoto,Yosuke Tamura,Kaoru Tanaka,Yasuhito Fujisaka,Isao Goto,Hiroyasu Kaneda,Takayasu Kurata,Hiroshige Yoshioka,Kazuhiko Nakagawa

Phase I/II study of nab-paclitaxel (nab-P) with cisplatin (C) and thoracic radiation (TRT) in patients with locally advanced NSCLC: Safety results of phase I part.

2016

Hidetoshi Hayashi
Masakazu Ogura
Takashi Niwa
Satoshi Ikeo
Takashi Yokoi
Yoshitaro Torii
Kunio Okamoto
Yosuke Tamura
Kaoru Tanaka
Yasuhito Fujisaka
Isao Goto
Hiroyasu Kaneda
Takayasu Kurata
Hiroshige Yoshioka
Kazuhiko Nakagawa

e20042Background: Concurrent platinum-based chemotherapy with thoracic radiation therapy (TRT) is well established with standard therapy in locally advanced NSCLC pts. Nanoparticle albumin-bound pa...

Keywords:

Nab-paclitaxel
Cisplatin
Oncology
Pathology
Internal medicine
Medicine
thoracic radiation
standard therapy
in patient
Chemotherapy
locally advanced
phase i ii

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations